Fengyun Shen
- Biomaterials top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 5
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 6
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 10
-
- Alzheimer's disease research and treatments 5
-
- CAR-T cell therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Journals
- Angewandte Chemie International Edition (3 papers)Biomaterials (2 papers)Advanced Materials (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Fengyun Shen
25 papers receiving 821 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 210
- Immunology 239
- Biomedical Engineering 491
- Molecular Medicine 29
- Molecular Biology 328
Countries citing papers authored by Fengyun Shen
This map shows the geographic impact of Fengyun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengyun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengyun Shen more than expected).
Fields of papers citing papers by Fengyun Shen
This network shows the impact of papers produced by Fengyun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengyun Shen. The network helps show where Fengyun Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fengyun Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 29 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 62 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 44 | |
| 13 | 2022 | 39 | |
| 14 | 2022 | 27 | |
| 15 | 2021 | 194 | |
| 16 | 2021 | 29 | |
| 17 | 2020 | 94 | |
| 18 | 2020 | 70 | |
| 19 | 2020 | 3 | |
| 20 | 2019 | 27 |
About Fengyun Shen
Fengyun Shen is a scholar working on Immunology, Biological Psychiatry and Molecular Biology, having authored 26 papers that have together received 829 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers), Nanoplatforms for cancer theranostics (6 papers), Alzheimer's disease research and treatments (5 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Biomaterials (210 citations), Immunology (239 citations) and Biomedical Engineering (491 citations). Fengyun Shen has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Zhuang Liu, Lele Sun, Jun Xu, Zijian Xiong, Rui Peng, Chunhai Fan, Huiquan Tao, Longlong Tian, Liangzhu Feng and Danlei Tao. Their work appears in journals such as Angewandte Chemie International Edition, Biomaterials, Advanced Materials, Nano Letters and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.